Streetbeat News

Analyst Ratings

BMY

GSK

INCY

The FDA has approved GSK's Ojjaara for intermediate or high-risk myelofibrosis in adults with anemia. William Blair notes that despite Ojjaara failing to beat Incyte's Jakafi in head-to-head trials, its lower transfusion burden could pressure Jakafi's market dominance. William Blair estimates a gradual decrease in Jakafi's market share, lowering its peak sales by $125 million to $150 million.

Portfolio Pulse from Vandana Singh

September 18, 2023 | 5:59 pm

LH

Baird analyst Eric Coldwell maintains an Outperform rating on Laboratory Corp (NYSE:LH) but lowers the price target from $251 to $237.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:55 pm

JBHT

B of A Securities analyst Ken Hoexter maintains a Buy rating on JB Hunt Transport Servs (NASDAQ:JBHT) and raises the price target from $207 to $216.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:53 pm

GNL

BTIG analyst Michael Gorman maintains a Buy rating on Global Net Lease (NYSE:GNL) but lowers the price target from $19 to $15.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:52 pm

LEN

BTIG analyst Carl Reichardt maintains a Buy rating on Lennar (NYSE:LEN) and raises the price target from $148 to $161.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:50 pm

AEP

CFRA analyst Daniel Rich maintains a 'Buy' rating on American Electric Power (NASDAQ:AEP) but lowers the price target from $99 to $94.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:49 pm

UPS

Oppenheimer analyst Scott Schneeberger has maintained an 'Outperform' rating on United Parcel Service (UPS) but lowered the price target from $195 to $184.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:47 pm

AMGN

Argus Research analyst David Toung maintains a 'Buy' rating on Amgen (NASDAQ:AMGN) and raises the price target from $260 to $280.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:46 pm

COST

A significant amount of unusual options activity has been observed for Costco Wholesale (NASDAQ:COST), with a mix of bullish and bearish stances. The trades have targeted a price range of $530.0 to $650.0 for Costco over the last 3 months. The current price of COST is up 1.26% at $563.38. Analysts from Stifel, Telsey Advisory Group, and Evercore ISI Group have given price targets of $575 and $600, with ratings of Buy and Outperform.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 5:46 pm

LRCX

Unusual options activity has been observed for Lam Research (NASDAQ:LRCX), with a large position indicating a bullish stance. The overall sentiment of these big-money traders is split between 53% bullish and 46% bearish. The whales have been targeting a price range from $570.0 to $700.0 for Lam Research over the last 3 months. Wolfe Research has downgraded its action to Outperform with a price target of $825, while Stifel maintains their Buy rating with a price target of $750.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 5:46 pm